Evidence map›Paper›PMID 23288169›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.

Jiao-Hui Wu, Alexander C Fanaroff, Krishn C Sharma, Liisa S Smith, Leigh Brian, Betty A Eipper, Richard E Mains, Neil J Freedman, Lisheng Zhang

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Association between Serum Kalirin Levels and theThe journal of Tehran Heart Center · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jiao-Hui WuDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Alexander C Fanaroff
Krishn C Sharma
Liisa S Smith
Leigh Brian
Betty A Eipper
Richard E Mains
Neil J Freedman
Lisheng Zhang
UConn Health · US

Funding

CELL BIOLOGY OF BIOACTIVE PEPTIDE SECRETIONR01DK032948 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI EIPPER, ELIZABETH ANNE, MAINS, RICHARD E · 1986 to 2019
$7.3M
Desensitization of Vascular Receptor Tyrosine KinasesR01HL077185 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 2005 to 2009
$1.9M
Mechanisms of Arterial Wall-Mediated AtherogenesisR01HL073005 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 2005 to 2008
$1.5M
Cell Biology of Bioactive Peptide SecretionR56DK032948 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAINS, RICHARD E · 2008 to 2008
$303k
CELL BIOLOGY OF BIOACTIVE PEPTIDE SECRETIONR37DK032948 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MAINS, RICHARD E · 1990 to 1998
–
NHLBI NIH HHS HL73005NHLBI NIH HHS HL77185NHLBI NIH HHS R01 HL073005NHLBI NIH HHS R01 HL077185NIDDK NIH HHS DK32948NIDDK NIH HHS R01 DK032948NIDDK NIH HHS R56 DK032948
6 · The paper itself

Abstract

objectiveKalirin is a multifunctional protein that contains 2 guanine nucleotide exchange factor domains for the GTPases Rac1 and RhoA. Variants of KALRN have been associated with atherosclerosis in humans, but Kalirin's activity has been characterized almost exclusively in the central nervous system. We therefore tested the hypothesis that Kalirin functions as a Rho-guanine nucleotide exchange factor in arterial smooth muscle cells (SMCs). APPROACH AND

resultsKalirin-9 protein is expressed abundantly in aorta and bone marrow, as well as in cultured SMCs, endothelial cells, and macrophages. Moreover, arterial Kalirin was upregulated during early atherogenesis in apolipoprotein E-deficient mice. In cultured SMCs, signaling was affected similarly in 3 models of Kalirin loss-of-function: heterozygous Kalrn deletion, Kalirin RNAi, and treatment with the Kalirin Rho-guanine nucleotide exchange factor -1 inhibitor 1-(3-nitrophenyl)-1H-pyrrole-2,5-dione. With reduced Kalirin function, SMCs showed normal RhoA activation but diminished Rac1 activation, assessed as reduced Rac-GTP levels, p21-activated kinase autophosphorylation, and SMC migration. Kalrn(-/+) SMCs proliferated 30% less rapidly than wild-type SMCs. Neointimal hyperplasia engendered by carotid endothelial denudation was ≈60% less in Kalrn(-/+) and SMC-specific Kalrn(-/+) mice than in control mice.

conclusionsKalirin functions as a guanine nucleotide exchange factor for Rac1 in SMCs, and promotes SMC migration and proliferation both in vitro and in vivo.

Indexed as

NeointimaAnimalsCarotid ArteriesCarotid Artery InjuriesCell MovementCell ProliferationCells, CulturedDisease Models, AnimalEndothelial CellsEnzyme ActivationGenotypeGuanine Nucleotide Exchange FactorsHyperplasiaMacrophagesMiceMice, Inbred C57BLGuanine Nucleotide Exchange FactorsKALRN protein, mouseNeuropeptidesp21-Activated KinasesProtein Kinase Inhibitorsrac1 GTP-Binding ProteinRac1 protein, mouserac GTP-Binding ProteinsrhoA GTP-Binding ProteinRhoA protein, mouserho GTP-Binding Proteins

Identifiers

PMID23288169
PMCPMC3638886
OpenAlexW2037757052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.